SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-24-005089
Filing Date
2024-11-14
Accepted
2024-11-14 15:31:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 armistice-ikt093024.htm SC 13G 88837
  Complete submission text file 0001172661-24-005089.txt   90420
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Subject) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92155 | Film No.: 241461031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)